AndrewThomasCatanzaroMD

Infectious Disease • Washington, DC

Washinton Advetist Infection Control, Antibiotic Stewardship Physician Leader

Join to view full profile

Dr. Catanzaro is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Catanzaro's full profile

Already have an account?

Office
Phoenix Center at Unity Health Care
1900 Mass Ave SE
Washington, DC 20003
Phone+1 202-548-6500

Fax+1 202-355-7601

Education & Training

MedStar Health/Georgetown University HospitalFellowship, Infectious Disease, 1995 - 1996
MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 1992 - 1995
Virginia Commonwealth University School of MedicineClass of 1992

Certifications & Licensure

MD State Medical License 2013 - 2026
DC State Medical License 1997 - 2014
VA State Medical License 1993 - 2000

Publications & Presentations

PubMed

23 citations
Efficacy and safety of CD24Fc in hospitalised patients with COVID-19: a randomised, double-blind, placebo-controlled, phase 3 study.
James Welker, Juan D Pulido, Andrew T Catanzaro, Carlos D Malvestutto, Zihai Li
The Lancet. Infectious Diseases. 2022-05-01

Press Mentions

PhaseBio Doses First Patient in VANGARD Phase 2 Clinical Trial to Evaluate PB1046 for Hospitalized COVID-19 PatientsJuly 16th, 2020